166 related articles for article (PubMed ID: 7654178)
21. Kinetics of coagulation factor X activation by platelet-bound factor IXa.
Rawala-Sheikh R; Ahmad SS; Ashby B; Walsh PN
Biochemistry; 1990 Mar; 29(10):2606-11. PubMed ID: 2110473
[TBL] [Abstract][Full Text] [Related]
22. Baculovirus-mediated expression of the epidermal growth factor-like modules of human factor IX fused to the factor XIIIa transamidation site in fibronectin. Evidence for a direct interaction between the NH2-terminal epidermal growth factor-like module of factor IXa beta and factor X.
Astermark J; Sottile J; Mosher DF; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3690-7. PubMed ID: 7906269
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.
Panteleev MA; Saenko EL; Ananyeva NM; Ataullakhanov FI
Biochem J; 2004 Aug; 381(Pt 3):779-94. PubMed ID: 15104540
[TBL] [Abstract][Full Text] [Related]
24. Binding studies of the enzyme (factor IXa) with the cofactor (factor VIIIa) in the assembly of factor-X activating complex on the activated platelet surface.
Ahmad SS; London FS; Walsh PN
J Thromb Haemost; 2003 Nov; 1(11):2348-55. PubMed ID: 14629468
[TBL] [Abstract][Full Text] [Related]
25. An ordered sequential mechanism for Factor IX and Factor IXa binding to platelet receptors in the assembly of the Factor X-activating complex.
Yang X; Walsh PN
Biochem J; 2005 Aug; 390(Pt 1):157-67. PubMed ID: 15755260
[TBL] [Abstract][Full Text] [Related]
26. Structural and functional characterization of platelet receptor-mediated factor VIII binding.
Ahmad SS; Scandura JM; Walsh PN
J Biol Chem; 2000 Apr; 275(17):13071-81. PubMed ID: 10777612
[TBL] [Abstract][Full Text] [Related]
27. Ca2+ binding to the first epidermal growth factor-like domain of human blood coagulation factor IX promotes enzyme activity and factor VIII light chain binding.
Lenting PJ; Christophe OD; Maat H; Rees DJ; Mertens K
J Biol Chem; 1996 Oct; 271(41):25332-7. PubMed ID: 8810297
[TBL] [Abstract][Full Text] [Related]
28. The factor IXa heparin-binding exosite is a cofactor interactive site: mechanism for antithrombin-independent inhibition of intrinsic tenase by heparin.
Yuan QP; Walke EN; Sheehan JP
Biochemistry; 2005 Mar; 44(9):3615-25. PubMed ID: 15736971
[TBL] [Abstract][Full Text] [Related]
29. Binding of coagulation factor IXa to procoagulant platelets revisited: Low affinity and interactions with other factors.
Soloveva PA; Podoplelova NA; Panteleev MA
Biochem Biophys Res Commun; 2024 Aug; 720():150099. PubMed ID: 38749192
[TBL] [Abstract][Full Text] [Related]
30. Platelet procoagulant complex assembly in a tissue factor-initiated system.
Monroe DM; Roberts HR; Hoffman M
Br J Haematol; 1994 Oct; 88(2):364-71. PubMed ID: 7803283
[TBL] [Abstract][Full Text] [Related]
31. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
Sheehan JP; Kobbervig CE; Kirkpatrick HM
Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
[TBL] [Abstract][Full Text] [Related]
32. The factor VIIIa C2 domain (residues 2228-2240) interacts with the factor IXa Gla domain in the factor Xase complex.
Soeda T; Nogami K; Nishiya K; Takeyama M; Ogiwara K; Sakata Y; Yoshioka A; Shima M
J Biol Chem; 2009 Feb; 284(6):3379-88. PubMed ID: 19047063
[TBL] [Abstract][Full Text] [Related]
33. Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIa.
Larson PJ; Stanfield-Oakley SA; VanDusen WJ; Kasper CK; Smith KJ; Monroe DM; High KA
J Biol Chem; 1996 Feb; 271(7):3869-76. PubMed ID: 8632006
[TBL] [Abstract][Full Text] [Related]
34. The role of electrostatic interactions in the assembly of the factor X activating complex on both activated platelets and negatively-charged phospholipid vesicles.
London F; Walsh PN
Biochemistry; 1996 Sep; 35(37):12146-54. PubMed ID: 8810922
[TBL] [Abstract][Full Text] [Related]
35. Assembly of the intrinsic factor X activating complex--interactions between factor IXa, factor VIIIa and phospholipid.
van Dieijen G; van Rijn JL; Govers-Riemslag JW; Hemker HC; Rosing J
Thromb Haemost; 1985 Jun; 53(3):396-400. PubMed ID: 3931288
[TBL] [Abstract][Full Text] [Related]
36. Zymogen factor IX potentiates factor IXa-catalyzed factor X activation.
London FS; Walsh PN
Biochemistry; 2000 Aug; 39(32):9850-8. PubMed ID: 10933803
[TBL] [Abstract][Full Text] [Related]
37. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex.
Panteleev MA; Ananyeva NM; Greco NJ; Ataullakhanov FI; Saenko EL
J Thromb Haemost; 2005 Nov; 3(11):2545-53. PubMed ID: 16241952
[TBL] [Abstract][Full Text] [Related]
38. Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
McCord DM; Monroe DM; Smith KJ; Roberts HR
J Biol Chem; 1990 Jun; 265(18):10250-4. PubMed ID: 2355000
[TBL] [Abstract][Full Text] [Related]
39. The influence of sodium ion binding on factor IXa activity.
Gopalakrishna K; Rezaie AR
Thromb Haemost; 2006 Jun; 95(6):936-41. PubMed ID: 16732371
[TBL] [Abstract][Full Text] [Related]
40. Functional difference between intrinsic and extrinsic coagulation pathways. Kinetics of factor X activation on human monocytes and alveolar macrophages.
McGee MP; Li LC
J Biol Chem; 1991 May; 266(13):8079-85. PubMed ID: 1902470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
